Homebiotech

biotech

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Awakening dormant immune cells inside tumours to attack cancer

Jim Cornall - January 5, 2026

biotech

CRISPR screen reveals genes required for brain development and a new neurodevelopmental disorder

Jim Cornall - January 5, 2026

biotech

Osaka looks to become global life sciences hub

Jim Cornall - January 5, 2026

biotech

Positive data moving breast cancer trial forward

Jim Cornall - December 24, 2025

biotech

Engineering dendritic cells boosts cancer immunotherapy

Jim Cornall - December 24, 2025

biotech

Ambros Therapeutics launches with $125m to take on complex regional pain syndrome type 1

Jim Cornall - December 23, 2025

biotech

ADEL and Sanofi sign $1.04bn licence agreement for Alzheimer’s therapy

Jim Cornall - December 23, 2025

biotech

Aukera Therapeutics emerges from stealth

Jim Cornall - December 23, 2025

1...313233...78 Page 32 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026 0

Avaí Bio, Inc., an emerging biotechnology company developing cell-based therapies for diabetes, age-related disorders, and anti-aging, has announced - together with its joint venture...

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0